Ixtlan Bioscience Announces the Filing of New Patent for the Psilocybin Treatment of Alzheimer’s Disease and Brain Pathologies
Evidence suggests that microdosing improves cognitive function and memory. This kit could take the benefits up a notch.👇🏽
Ixtlan Bioscience, a private Israeli company, filed a US patent for a microdosing kit that can be used at home to treat Alzheimer’s, brain damage, and neuronal disorders.
The kit includes:
- Psilocybin capsules
- Games and exercises to enhance the benefits of microdosing
- A web application that patients can use to track their progress.
Who knows, maybe this time next year, it’ll be the trending gift to put under the tree. 🎄